Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xiao‑Feng Liao
Doxorubicin Resistance Induces IL6 Activation in the Colon Cancer Cell Line LS180
Oncology Letters
Cancer Research
Oncology
Related publications
Establishment and Characterization of a Bladder Cancer Cell Line With Enhanced Doxorubicin Resistance by Mevalonate Pathway Activation
Tumor Biology
Medicine
Cancer Research
RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Dragon (RGMb) Induces Oxaliplatin Resistance in Colon Cancer Cells
Oncotarget
Oncology
Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
Molecular Cell
Cell Biology
Molecular Biology
MicroRNA-522 Reverses Drug Resistance of Doxorubicin-Induced HT29 Colon Cancer Cell by Targeting ABCB5
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
[Corrigendum] Activation of Platelet Protease-Activated Receptor-1 Induces Epithelial-Mesenchymal Transition and Chemotaxis of Colon Cancer Cell Line SW620
Oncology Reports
Medicine
Cancer Research
Oncology
Isolation and Characterization of a Human Colon Adenocarcinoma Cell Line Resistant to Doxorubicin
British Journal of Cancer
Cancer Research
Oncology
Hypoxia-Inducible Factor-1α Induces Multidrug Resistance Protein in Colon Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Octaarginine-Modified Gold Nanoparticles Enhance the Radiosensitivity of Human Colorectal Cancer Cell Line LS180 to Megavoltage Radiation
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
